SKI Market

A+| A| A-|

Indian Indices

Sensex

75,527.95 1,695.40
( 2.30%)

Global Indices

Nasdaq

51,233.54 363.79
(0.72%)

Dow Jones

7,453.14 37.84
(0.51%)

Hang Seng

66,063.56 1,846.29
(2.88%)

Nikkei 225

10,460.24 156.36
(1.52%)

Forex

USD-INR

95.49 0.16
(0.17%)

EUR-INR

110.25 0.17
(0.15%)

GBP-INR

127.74 0.15
(0.12%)

JPY-INR

0.60 0.00
(0.21%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Haleos Labs Limited

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

540679

INE320X01016

709.7350897

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

HALEOSLABS

23.06

409.96

EPS(TTM)

Face Value()

Div & Yield %

58.8

0.11

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	368.35	328.75	351.88	379.12	286.88	282.61
Excise Duty	34.98	28.75	36.63	33.49	26.63	25.68
Net Sales	333.37	300.00	315.25	345.63	260.25	256.93
Other Income	3.95	3.84	5.23	14.23	1.33	1.88
Stock Adjustments	-4.69	-0.98	-0.30	7.79	-1.90	-6.29
Total Income	332.63	302.86	320.18	367.65	259.68	252.52
EXPENDITURE :
Raw Materials	164.43	161.19	189.95	216.16	137.76	155.75
Power & Fuel Cost	27.17	26.46	25.66	26.32	19.52	18.73
Employee Cost	45.78	40.92	34.72	32.51	27.11	23.27
Other Manufacturing Expenses	28.51	24.19	24.08	32.06	27.22	18.91
Selling & Administrative Expenses	11.31	9.62	11.69	13.20	11.94	8.99
Miscellaneous Expenses	7.19	2.10	2.36	1.74	5.01	1.17
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	284.39	264.49	288.46	321.99	228.55	226.83
Operating Profit	48.24	38.38	31.71	45.65	31.14	25.68
Interest	7.94	9.01	5.16	4.68	4.57	5.10
Gross Profit	40.30	29.37	26.55	40.97	26.57	20.58
Depreciation	10.26	10.25	8.17	7.99	7.21	7.24
Profit Before Tax	30.04	19.12	18.38	32.98	19.36	13.34
Tax	8.81	4.05	3.15	7.56	5.03	3.30
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-0.14	1.99	2.01	0.04	1.16	0.89
Reported Net Profit	21.37	13.07	13.22	25.38	13.17	9.15
Extraordinary Items	0.02	0.00	1.87	9.47	0.01	0.06
Adjusted Net Profit	21.35	13.07	11.35	15.91	13.16	9.09
Adjustment below Net Profit	0.03	-0.41	0.05	-0.05	-0.09	-0.42
P & L Balance brought forward	101.03	90.83	80.02	57.14	45.06	36.79
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	2.45	2.45	2.45	2.45	1.00	0.45
P & L Balance carried down	119.98	101.03	90.83	80.02	57.14	45.06
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	15.00	15.00	15.00	15.00	15.00	0.00
Dividend Per Share(Rs)	1.50	1.50	1.50	1.50	1.50	0.00
Earnings Per Share-Unit Curr	70.69	43.22	43.72	83.95	43.56	30.26
Earnings Per Share(Adj)-Unit Curr	70.69	43.22	43.72	83.95	43.56	30.26
Book Value-Unit Curr	652.19	582.90	542.55	500.16	417.88	374.61
Book Value(Adj)-Unit Curr	652.19	582.90	542.55	500.16	417.88	374.61

75,527.95 1,695.40 ( 2.30%)

51,233.54 363.79 (0.72%)

7,453.14 37.84 (0.51%)

66,063.56 1,846.29 (2.88%)

10,460.24 156.36 (1.52%)

95.49 0.16 (0.17%)

110.25 0.17 (0.15%)

127.74 0.15 (0.12%)

0.60 0.00 (0.21%)